No abstract

Although there are a lot of studies to examine the association LUTS and sexual dysfunction with MetS in men, there are limited number studies to evaluate this association in women. We found that although the prevalence of LUTS and sexual dysfunction in women with MetS was higher than women without MetS, LUTS in these women with MetS did not significantly affect quality of life. ABSTRACTWhat's known on the subject? and What does the study add? ÖZET objectiveTo assess lower urinary tract symptoms and sexual function in premenopausal women with metabolic syndrome (MetS).

No abstract

We present here a case with coexistence of extramedullary plasmacytoma (EMP) and Autoimmune hepatitis (AH), in the pathogenesis of which there is mononuclear cell infiltration including plasma cells, and hyperimmunoglobulinemia which is characterized particularly with an increase in IgG.Pam Med J 2015;8(3):243-246

Background and Aims: Upper gastrointestinal tract malignancies are among the major causes of morbidity and mortality worldwide. Esophagogastroduodenoscopy is the gold standard for the diagnosis of upper gastrointestinal tract cancers. The aim of our study was to determine features of upper gastrointestinal tract malignancies including age, gender, localization, histological types and symptoms prior to the procedure in the cases that were identified by in our endoscopy unit and finally diagnosed by biopsy. Materials and Methods: A total of 209 (2.71%) of 7.688 patients who underwent esophagogastroduodenoscopy in our endoscopy unit and who were diagnosed with malignancy were included in the study. Results: Of the patients diagnosed with malignancy by esophagogastroduodenoscopy, 145 were men (69,4%) and 64 were women (30,6%). Mean age was 62.18±12.07 years. In the sample, 21.1% of malignant tumors were detected in the esophagus, 75.1% in the stomach, and 3.8% in the duodenum. Histopathological examination showed that 84.1% of esophageal tumors were squamous cell carcinoma, and 15.9% were adenocarcinoma; 87.9% of gastric tumors were adenocarcinoma, 3.8% were malignant epithelial tumors, 5.8% were lymphoma, and 2.5% were neuroendocrine tumors; 87.5% of duodenal tumors were adenocarcinoma, and 12.5% were malignant epithelial tumors. Conclısions: Upper gastrointestinal tract malignancies are most common in the stomach, and the second most common organ is esophagus. Although rare, tumors can be seen in the duodenum.